Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Ultragenyx Pharmaceutical
1 program
triheptanoinN/A1 trial
Active Trials
NCT01461304No Longer Available

Clinical Trials (1)

NCT01461304Ultragenyx Pharmaceuticaltriheptanoin

Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism

N/ANo Longer Available

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space